Paired Ends: Carl Gordon


Carl Gordon will be resigning from the board of directors of Complete Genomics, the company disclosed last week in a filing with the US Securities and Exchange Commission.

Complete Genomics said the resignation, which is effective immediately, "is not because of a disagreement with the company on any matter relating to the company’s operations, policies, or practices."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.